Clinical Trials
14 trialsNCT03520660 2026-05-22
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT01082419 2026-05-14
NARFI
University Hospital, Bordeaux
Phase NA Completed
NCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT02968810 2026-05-04
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06096779 2026-05-04
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT02626312 2026-04-30
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05637216 2026-04-24
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Shaw Cancer Center
Phase 2 Recruiting
NCT03612531 2026-04-23
MANTLE
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05486572 2026-04-21
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT07529262 2026-04-14
AspiRe HCC
Curtin University
Phase 3 Not yet recruiting
NCT05874492 2026-04-13
FIBROTHERME
Association Francaise pour la Recherche Thermale
Phase NA Recruiting
NCT05586516 2026-03-30
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
iOnctura
Phase 1/2 Completed
NCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
NCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting